The risk of a multiple myeloma in patients with paraproteinaemia: A myeloma risk score developed in the region of the Comprehensive Cancer Centre West;De kans op de ziekte van kahler (multipel myeloom) bij patienten met een paraproteinemie: Myeloomrisicoscore, ontwikkeld in de regio van het Integraal Kankercentrum West

Nederlands Tijdschrift voor Geneeskunde

Volumn 142, Issue 28, 1998, Pages 1591-1595

  Schaar, C G ^a   Ong, F ^b   Snijder, S ^c   Wijermans, P W ^d   Franck, P F H ^d   Kluin Nelemans, J C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c Integraal Kankercentrum West   (Netherlands)

^d LEYENBURG HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; BONE MARROW EXAMINATION; HEMATOLOGIC DISEASE; HUMAN; MAJOR CLINICAL STUDY; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; NETHERLANDS; PARAPROTEINEMIA; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; X RAY ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE MARROW; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MULTIPLE MYELOMA; NETHERLANDS; PARAPROTEINEMIAS; RISK ASSESSMENT; ROC CURVE;

EID: 0032508195     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. Foerster J. Plasma cell dyscrasias: general considerations. In: Lee GR, Bitchell TC, Foerster J, Athens JW, Lukens JN, editors. Wintrobe's clinical hematology. 9th ed. Philadelphia: Lea & Febiger, 1993:2202-18.
2. Kyle RA. 'Benign' monoclonal gammopathy - after 20 to 35 years of follow-up. Mayo Clin Proc 1993;68:26-36.
3. Kyle RA. Monoclonal gammopathy of undetermined significance (MGUS). Baillieres Clin Haematol 1995;8:761-81.
4. Ligthart GJ, Radl J, Corberand JX, Nieuwkoop JA van, Staalduinen GJ van, Helmond DJ van, et al. Monoclonal gammopathies in human aging: increased occurrence with age and correlation with health status. Mech Ageing Dev 1990;52:235-43.
5. Radl J, Sepers JM, Skvaril F, Morell A, Hijmans W. Immunoglobulin patterns in humans over 95 years of age. Clin Exp Immunol 1975;22:84-90.
6. Dinkelaar RB, Holdrinet RSG. Beleid bij paraproteinemie. Ned Tijdschr Geneeskd 1991;135:2223-6.
7. Dinkelaar RB, Beunis MH, Casparie AF, Dinant GJ, Everdingen JJE van, Holdrinet RSG, redacteuren. Onderzoek bij paraproteïnemie CBO rapport 1990. Utrecht: CBO, 1990.
8. Ong F, Hermans J, Noordijk EM, Kieviet W de, Wijermans PW, Seelen PJ, et al. Developing a population-based registry for patients with paraproteinemias or multiple myeloma. J Clin Epidemiol 1997;50:909-15.
9. Ong F, Hermans J, Noordijk EM, Wijermans PW, Seelen PJ, Kieviet W de, et al. A population-based registry on paraproteinaemia in the Netherlands. BMJ 1997;99:914-20
10. Ong F, Hermans J, Noordijk EM, Kluin-Nelemans JC. Is the Durie and Salmon diagnostic classification system for plasma cell dyscrasias still the best choice? Application of three classification systems to a large population-based registry of paraproteinemia and multiple myeloma. Ann Hematol 1995;70:19-24.
11. Ong F, Hermans J, Noordijk EM, Kieviet W de, Seelen PJ, Wijermans PW, et al. Development of a 'Myeloma Risk Score' using a population based-registry on paraproteinemia and myeloma. Leuk Lymphoma 1997;27:495-501.